“…Although asperphenamate is mainly known for its antitumour activity and immense synthetic chemists interest in asperphenamate backbone modification ( Li et al, 2012 ; Yuan et al, 2012 , 2018 , 2019 , 2020 ; Liu et al, 2016 ), recent studies have also shown asperphenamate to be a potential neuroinflamatory inhibitor ( Zhou et al, 2017 ), and to possess anti-HIV ( Bunteang et al, 2018 ) and antidiabetic ( Del Valle et al, 2016 ) properties. In recent years, a handful of new natural analogs have been isolated, namely Asperphenamates B ( 4 ) and C ( 5 ) ( Liu et al, 2018 ), and 4-OMe-asperphenamate ( Zheng et al, 2013 ; Ratnaweera et al, 2016 ) ( 6 ) from filamentous fungi. Other analogs containing partial structural similarities include: patriscabratine ( 7 ), a N-benzoylphenylalanine phenylalanynol acetate ester, aurantiamide ( 8 ) and aurantiamide acetate ( 9 ) ( Zhou et al, 2017 ), N-benzoylphenylalanine phenylalanynol and phenylalanynol acetate amides, all isolated from plant material; cordyceamides A ( 10 ) and B ( 11 ) ( Jia et al, 2009 ), a N-benzoyl-L-tyrosinyl-L-phenylalaninol and N-benzoyl-L-tyrosinyl-L- p -hydroxyphenylalaninol acetates, from an insect pathogen fungus ( Figure 1 ); along with a number of tentatively identified related metabolites ( Kildgaard et al, 2014 ; Sica et al, 2016 ).…”